ArticleBiomedicines2025

Synergistic Anticancer Activity of HSP70 Inhibitor and Doxorubicin in Gain-of-Function Mutated p53 Breast Cancer Cells.

Kuan-Yo Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.